Market revenue in 2023 | USD 5.7 million |
Market revenue in 2030 | USD 11.3 million |
Growth rate | 10.2% (CAGR from 2023 to 2030) |
Largest segment | Monoclonal antibodies |
Fastest growing segment | Recombinant antibodies |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Monoclonal antibodies, Polyclonal antibodies, Recombinant antibodies, Other Type |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to custom antibody market will help companies and investors design strategic landscapes.
Monoclonal antibodies was the largest segment with a revenue share of 50.88% in 2023. Horizon Databook has segmented the Canada custom antibody market based on monoclonal antibodies, polyclonal antibodies, recombinant antibodies, other type covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada custom antibody market , including forecasts for subscribers. This country databook contains high-level insights into Canada custom antibody market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account